Infection prevention and control (IPC) best practices were already in place against threats such as influenza before the pandemic crisis. During and after the immediate crisis, multiple approaches and practices arose in response to changing knowledge and guidance. Where are we now—and what is needed for today and into the future?
- Rhonda DeMeno, Director of Clinical Risk, Willis Towers Watson
- Megan Crosser, Director of Infection Prevention, nodMD
Moderator: John M. Schulte, Vice President, Quality Improvement, Argentum